MPG.eBooks - Author Search Results

161

Clinical review report: Vortioxetine hydrobromide (Trintellix) (Lundbeck Canada Inc.) : indication: the treatment of major depressive disorder in adults

Published 2020

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

162

Clinical review report: Teduglutide (Revestive) (Shire Pharmaceuticals Ireland Limited) : indication: treatment of adults and pediatric patients one year of age and above with shor...

Published 2020

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

163

Intranasal and intramuscular naloxone for opioid overdose in the pre-hospital setting : a review of comparative clinical and cost-effectiveness, and guidelines

by Peprah, Kwakye, Severn, Melissa
Published 2019

CADTH

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

164

Continuously diffused oxygen therapy for wound healing : a review of the clinical effectiveness, cost-effectiveness, and guidelines

by Edge, Rob, Frey, Nina
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

165

Pharmacoeconomic review report: Certolizumab pegol (Cimzia) : (UCB Canada Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasis who are...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

166

Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : for the treatment of adult patients with active ankylosing spondylitis who have responded inadequa...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

167

Clinical review report (resubmission): OnabotulinumtoxinA (BOTOX) (Allergan inc.) : indication : for the prophylaxis of headaches in adults with chronic migraine ([equal or less] 1...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

168

Clinical review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication : indicated in addition to standard therapy for reducing disease activity in adult patients with ac...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

169

Clinical review report: Dupilumab (Dupixent) (Sanofi genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of patients aged 12 years and old...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

170

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication : for the treatment of adult patients with moderately to severely acti...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

171

Quetiapine for major depressive disorder : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Tran, Khai, Argáez, Charlene
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

172

Pharmacogenomic testing in depression : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Li, Ke Xin, Loshak, Hannah
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

173

Prostaglandin analogues for ophthalmic use : a review of comparative clinical effectiveness, cost-effectiveness, and guidelines

by Islam, Saadul, Spry, Carolyn
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

174

Combination use of ivabradine with sacubitril/valsartan : a review of clinical effectiveness and guidelines

by Pohar, Ron, MacDougall, Danielle
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

175

Masks for prevention of influenza transmission in acute and long-term care settings : a review of clinical effectiveness, cost-effectiveness and guidelines

by Marchand, Dave K., Argáez, Charlene
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

176

Psychotherapy and pharmacotherapy for major depressive disorder and generalized anxiety disorder : a rapid qualitative review

by Kandasamy, Sujane, Campbell, Kaitryn
Published 2019

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

177

Identification of tuberculosis : a review of the guidelines

by Brett, Kendra, Dulong, Camille, Severn, Melissa
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

178

Artificial intelligence for classification of lung nodules : a review of clinical utility, diagnostic accuracy, cost-effectiveness, and guidelines

by Lachance, Chantelle, Walter, Melissa
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

179

Prenatal and postnatal home visiting programs for parents, newborns, and babies : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Li, Ke Xin, Argáez, Charlene
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”

Read Now

180

Orthotic bracing or splinting of upper extremities in patients with chronic, non-cancer pain : a review of clinical effectiveness

by Peprah, Kwakye, MacDougall, Danielle
Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health...”